Freeze All on Oocyte Maturatin by Gonadotropin Agonist Versus Human Chorionic Gonadotroipin
Not Applicable
- Conditions
- Infertility
- Interventions
- Drug: Agonist (decapeptyl )
- Registration Number
- NCT04749979
- Lead Sponsor
- Aljazeera Hospital
- Brief Summary
Estradiol valerate in the form of cycloprogenova™ (white tablet only) was started on day 2 or 3 of cycle with oral dose 4 mg divided on 2 doses in addition to Aspocid 75 mg once daily with folic acid 500 mcg once daily.
- Detailed Description
U/S was done on day 9 or 10 of cycle to assess endometrial thickness, then every other day until endometrial thickness of 8 mm or more is reached and when endometrial thickness reaches 8 mm or more FET was planned. Progesterone in the form of prontogest™ 400 mg vaginal suppository twice dTwo to Four Day 5 Embryos was transferred
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
- PCOS patients according to Rotterdam criteria
- Female age between 20 and 40 years.
- Primary or secondary infertility.
- Body mass index (BMI) between 18 and 40 kg/m2.
Exclusion Criteria
-
Ovarian endometriosis.
- Ovarian cysts before induction.
- Known uncontrolled endocrinal abnormalities (like hypo or hyperthyroidism)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description giving agonist ( eg. decapeptyl ) Agonist (decapeptyl ) Giving women agonist Giving HCG (eg. choriomon ) HCG ( eg. Choriomon ) Giving women HCG
- Primary Outcome Measures
Name Time Method the number of good quality embryos within 5 months how many good quality embryos
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Aljazeera( Al Gazeera) hospital
🇪🇬Giza, Egypt